Transmyometrial Blastocyst Transfer in a Patient With Congenital Cervical Atresia  by Lin, Tseng-Kai et al.
Taiwan J Obstet Gynecol • September 2010 • Vol 49 • No 3
■ RESEARCH LETTER ■
366
Congenital atresia of the cervix, with or without vaginal
agenesis, is a rare Müllerian developmental disorder
[1,2]. The mechanisms causing cervical atresia remain
unknown. Primary amenorrhoea, together with cyclic
abdominal pain caused by hematometra, are the most
common clinical presentations. The aims of treatments
for this anomaly, which include reconstructive surgery,
are firstly to relieve the symptoms and secondly to restore
fertility and regular menstruation [3,4]. However, recon-
structive surgery may be associated with severe com-
plications such as pelvic inflammation or restenosis of
the neocanal, which can require hysterectomy in many
cases [5].
Assisted reproductive techniques (ART) increase
the chances of pregnancy and childbirth in patients
with congenital cervical atresia; four successful preg-
nancies have recently been reported in patients with
this condition following in vitro fertilization (IVF) and
transmyometrial embryo transfer (TMET) [6–9]. How-
ever, cleavage-stage embryos were transferred in all
these cases.
Herein, we describe a patient with complete cer-
vical atresia and vaginal dysgenesis who underwent a
successful pregnancy with a positive fetal heartbeat
after IVF treatment carried out using ultrasound-guided
transmyometrial blastocyst transfer (TMBT). To the
best of our knowledge, this represents the first reported
case of a successful pregnancy in a patient with com-
plete cervical atresia after TMBT.
A 33-year-old woman was referred to the outpatient
clinic of the reproductive medicine center at Cathay
General Hospital Hsichu Branch in 2005 suffering from
hypomenorrhea and a failure to become pregnant for
2 years. Her past history was remarkable for cyclic
abdominal pain and lack of menstruation since the
age of 14 years. Congenital complete cervical atresia
with a short vagina was diagnosed by a gynecologist 
at St. Joseph’s Hospital. She underwent simultaneous
reconstructive surgery to create a functional uterovaginal
passage and vaginoplasty to elongate the vaginal vault.
Regular menstrual cycles with a period of 28 days were
restored after surgery, and her cyclic abdominal pain
subsided. However, she still suffered from hypomenor-
rhea and persistent leukorrhea with a smelly odor.
Examination at our clinic revealed normal secondary
sexual maturation, including breast development and
pubic hair. Her height was 160 cm and her weight was
49 kg. She had a normal female karyotype of 46,XX.
Gynecologic examination demonstrated a 5-cm-long
vaginal vault with no cervix and a dilated lower seg-
ment of uterus, about 2 cm in diameter with an opening
to the vagina. Ultrasound examination revealed normal
ovaries and a normal-sized uterus with a thin (7 mm)
middle-secretory phase endometrium. Measurements of
serum follicle-stimulating hormone, luteinizing hormone,
estradiol, and progesterone suggested normal ovarian
function, but an increased prolactin level (40.5 ng/mL)
was detected. Her hyperprolactinemia resolved after
treatment with bromocriptine.
Hysterosalpingography showed bilateral tubal
obstruction (Figure 1). Laparoscopic examination con-
firmed the presence of bilateral obstructed Fallopian
tubes via chromopertubation. Severe pelvic adhesion
caused by chronic pelvic inflammation was also noted.
The uterine body and bilateral ovaries were normal.
Her husband’s semen analysis was normal.
The couple received counseling regarding their fer-
tility status, including the need for IVF-embryo transfer
(ET) therapy to establish a pregnancy because of tubal
occlusion; they decided to start treatment in July 2008.
After pituitary downregulation with a gonadotropin-
releasing hormone analog (Lupron), a total of 1,650 IU
recombinant follicle stimulating hormone (Gonal-F) and
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825 IU human menopausal gonadotropin (Merional)
were used for controlled ovarian hyperstimulation.
Transvaginal oocyte retrieval was performed 36 hours
after an intramuscular injection of 10,000 IU human
chorionic gonadotropin (hCG, Pregnyl). The endome-
trial thickness on the day of ovum retrieval was 12 mm.
Nine oocytes were retrieved, five of which were fertil-
ized. After 68 hours, four 8-cell embryos were selected
for transfer. Embryo transfer was initially attempted
through the uterovaginal canal, because we had previ-
ously successfully inserted a metal uterine probe via
this canal into the uterine cavity. However, embryo
transfer by this approach failed because it was difficult
to insert the soft embryo-transfer catheter through the
tortuous uterovaginal canal without the support of a
cervical clamp. We therefore extended the embryo culture
to day 5, and three out of four 8-cell embryos devel-
oped to one early blastocyst and two full expanded
blastocysts. All the three blastocysts were transferred via
TMBT under general anesthesia using a 5 MHz endo-
vaginal ultrasound probe and a “Towako” embryo
transfer catheter. The “Towako” needle with its stylet
was passed through the anterior vaginal fornix under
ultrasound guidance, then through the myometrium of
the anterior uterine wall with its adjacent endometrium,
and into the endometrium of the posterior wall. The nee-
dle was then pulled back gently into the uterine cavity
and the stylet was removed. A catheter loaded with the
embryos was introduced into the needle and the embryos
were transferred by gentle injection. Transvaginal ultra-
sound showed the presence of an echogenic air bub-
ble in the posterior endometrium of the uterus where
the blastocysts and culture medium were deposited
(Figure 2). Luteal support was maintained with daily
intramuscular progesterone-in-oil injections of 50 mg
and vaginal progesterone gel (Crinone 8%) 90 mg twice
daily.
A positive pregnancy test with a serum β-hCG level
of 173.89 mIU/mL was obtained 10 days after TMBT.
At 25 days after TMBT, serum β-hCG was 6,375 mIU/
mL and an intrauterine gestational sac, about 1.1 cm
in size, was detected by transabdominal ultrasound. 
A fetal pole with a crown–rump length of 5.2 mm and
the presence of a fetal heartbeat were detected 1 week
later (Figure 3). The fetal crown–rump length had
increased to 8 mm at 39 days after TMBT. However,
fetal cardiac activity was absent and a missed abortion
was diagnosed. Evacuation of the intrauterine mass by
laparotomy, whole-body or local injection of methotrex-
ate, oral mifepristone (RU486) therapy or conservative
observation were discussed as potential management
options for the abortion; the couple chose oral mifepri-
stone therapy. The patient received 600 mg mifepris-
tone and 600 mg misoprostol (U-miso) orally on day 44
post-TMBT. Vaginal bleeding began on the day after
medication. Six days after medication, serum β-hCG
was 1,110 mIU/mL and sonography revealed a 3.5-cm
hematoma within the lower part of the uterus (Figure 4).
Vaginal bleeding had ceased 16 days after medication
and serum β-hCG had decreased to 20 mIU/mL. No
signs or symptoms of infection occurred throughout
the medication period.
The probability of spontaneous pregnancy is low 
in patients with congenital cervical atresia, even fol-
lowing successful canalization surgery. This could be
attributable to the lack of normal endocervical canal
glandular function, severe endometriosis, or tubal prob-
lems secondary to the anomaly. Only three spontaneous
pregnancies in patients with this disease have previously
been reported [10–12].
ART, however, should enhance the chances of preg-
nancy in patients with congenital cervical atresia and
five successful pregnancies have been reported in patients
with this disease using ART. One patient became preg-
nant after zygote intra-Fallopian transfer [13] and three
Figure 1. Hysterosalpingography image showing bilateral
tubal obstruction.
Figure 2. The process of transmyometrial blastocyst transfer
under ultrasound guidance. Transvaginal ultrasound show-
ing an echogenic air bubble in the posterior endometrium of
the uterus where the blastocysts and their culture medium
were delivered (arrow).
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conceived after TMET with fresh or frozen-thawed
embryos [6,7,9]. One pregnancy was reported after
TMET and transtubal ET [8]. Cleavage-stage embryos
were selected for TMET in all these cases (Table).
ET at the blastocyst stage is known to be associated
with a higher implantation rate and a lower multiple
pregnancy rate compared with transfer at the cleavage
stage. In addition, blastocyst transfer provides oppor-
tunities to select more viable embryos and to place the
embryos into a more synchronized uterine environment
[14]. The current case represents the first pregnancy in
a patient with congenital cervical atresia arising from
IVF-TMET using blastocysts, rather than cleavage stage
embryos. Although this case resulted in a missed abor-
tion, our experience supports the possibility of preg-
nancy using TMBT in patients with congenital cervical
atresia.
Management of a missed abortion in patients with
congenital cervical atresia has also rarely been reported.
Traditional dilatation and curettage is difficult to 
perform in such patients because of the lack of cervix.
Although surgery, such as laparotomy or laparoscopy,
can be performed to remove the remaining intrauterine
mass, only one case of a patient having a complete abor-
tion using conservative observation without surgery or
medication has been reported [7].
In the present case, the patient decided to terminate
the missed abortion with mifepristone and complete
evacuation of the intrauterine mass occurred 16 days
after medication, with no signs of infection. To the best
of our knowledge, this is the first report of successful
termination of a missed abortion with mifepristone in
a woman with congenital cervical atresia. However, a
long follow-up period is required between administra-
tion of the medication and expulsion. We suggest that
surgical treatments to manage this condition, such as
laparoscopy or laparotomy, should only be offered as
last choices.
In conclusion, TMBT can result in pregnancy in
patients with congenital cervical atresia. Medical treat-
ment with mifepristone offers a viable alternative method
of termination for missed abortion in these patients.
Figure 3. Transabdominal ultrasound on day 32 after trans-
myometrial blastocyst transfer showing a positive fetal heart
beat and a fetal crown rump length of 0.52 cm.
Table. Summary of assisted reproductive techniques used in pregnant women with congenital cervical atresia
Authors Type of ART Embryo stage Outcome
Thijssen et al [13] ZIFT – Delivery at 38 wk gestation
Anttila et al [6] TMET 4-cell Delivery at 32 wk gestation
Lai et al [8] TMET + TET 8-cell Delivery at 36 wk gestation
Suganuma et al [7] TMET Cleavage stage Missed abortion and blighted ovum
Xu et al [9] TMET Cleavage stage Delivery at 30 wk gestation
Present study TMET Blastocyst Missed abortion and FHB (+)
ART = assisted reproductive technology; ZIFT = zygote intra-Fallopian transfer; TMET = transmyometrial embryo transfer; TET = transtubal embryo transfer;
FHB = fetal heart beat.
Figure 4. Six days after mifepristone and misoprostol med-
ication (50 days post-transmyometrial blastocyst transfer), 
a 3.5-cm hematoma can be detected within the lower part 
of the uterus. No gestational sac or fetus can be detected
(H = hematoma; UT = uterus; E = endometrium).
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